Skip to Main Content

If at first you don’t succeed …

After being rebuffed by the Obama administration, a consumer advocacy group is now asking the Trump administration to use federal law to widen access in the United States to a pricey prostate cancer drug that was developed with taxpayer funds.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!